bazedoxifene has been researched along with Fracture, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Hijikata, Y; Matsubara, Y; Watanabe, N | 1 |
| Chaki, O | 1 |
2 review(s) available for bazedoxifene and Fracture, Pathologic
| Article | Year |
|---|---|
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Topics: Antibodies, Monoclonal; Bias; Bone Density; Bone Density Conservation Agents; Denosumab; Female; Femur Neck; Fractures, Spontaneous; Hip; Humans; Indoles; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Parathyroid Hormone-Related Protein; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Spinal Fractures; Teriparatide; Thiophenes; Watchful Waiting | 2021 |
[Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene].
Topics: Animals; Breast Neoplasms; Cholesterol; Female; Fractures, Spontaneous; Hot Flashes; Humans; Indoles; Osteoporosis, Postmenopausal; Rats; Selective Estrogen Receptor Modulators; Uterus | 2007 |